Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Vincera Pharma Inc (VINC)

Vincera Pharma Inc (VINC)
0.6383 +0.0077 (+1.22%) 13:48 ET [NASDAQ]
0.6300 x 4 0.6383 x 3
Realtime by (Cboe BZX)
0.6300 x 4 0.6383 x 3
Realtime 0.6209 -0.0097 (-) 09:07 ET
Quote Overview for Thu, Mar 20th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.6209
Day High
0.6553
Open 0.6306
Previous Close 0.6306 0.6306
Volume 227,548 227,548
Avg Vol 1,627,573 1,627,573
Stochastic %K 4.87% 4.87%
Weighted Alpha -96.34 -96.34
5-Day Change -0.1833 (-22.50%) -0.1833 (-22.50%)
52-Week Range 0.5910 - 142.3560 0.5910 - 142.3560
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,412
  • Shares Outstanding, K 2,240
  • Annual Sales, $ 0 K
  • Annual Income, $ -40,160 K
  • EBIT $ -28 M
  • EBITDA $ -28 M
  • 60-Month Beta 1.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.12
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -15.80
  • Most Recent Earnings $-3.40 on 11/12/24
  • Next Earnings Date 04/04/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -2.60
  • Number of Estimates 1
  • High Estimate -2.60
  • Low Estimate -2.60
  • Prior Year -4.60
  • Growth Rate Est. (year over year) +43.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5910 +6.80%
on 03/19/25
Period Open: 1.2500
1.4300 -55.86%
on 02/27/25
-0.6188 (-49.50%)
since 02/20/25
3-Month
0.5910 +6.80%
on 03/19/25
Period Open: 4.1420
10.3740 -93.92%
on 12/30/24
-3.5108 (-84.76%)
since 12/20/24
52-Week
0.5910 +6.80%
on 03/19/25
Period Open: 134.0000
142.3560 -99.56%
on 03/21/24
-133.3688 (-99.53%)
since 03/20/24

Most Recent Stories

More News
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

VINC : 0.6383 (+1.22%)
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

VINC : 0.6383 (+1.22%)
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258

VINC : 0.6383 (+1.22%)
Vincerx Pharma, Inc. Announces Reverse Stock Split

VINC : 0.6383 (+1.22%)
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish

Retail sentiment on Stocktwits has remained ‘bullish’ on the stock.

VINC : 0.6383 (+1.22%)
VXF : 177.86 (-0.43%)
VTI : 278.53 (-0.31%)
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

VINC : 0.6383 (+1.22%)
Vincerx Pharma Announces Cost-Cutting Measures and Exploration of Strategic Alternatives to Advance VIP943 Clinical Development

Vincerx Pharma plans cost-controls and strategic alternatives to advance VIP943, a promising cancer treatment currently in Phase 1 study.Quiver AI SummaryVincerx Pharma, Inc. announced plans to implement...

VINC : 0.6383 (+1.22%)
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials

The company's plans include a 55% reduction in force and exploring strategic alternatives such as out-licensing, mergers, or asset sales.

VINC : 0.6383 (+1.22%)
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

VINC : 0.6383 (+1.22%)
Vincerx Pharma Reports Third Quarter 2024 Financial Results

VINC : 0.6383 (+1.22%)

Business Summary

Vincerx Pharma Inc. is a biopharmaceutical company. It focuses on unmet medical needs of patients with cancer through paradigm-shifting therapeutics. Vincerx Pharma Inc. is based in PALO ALTO, Calif.

See More

Key Turning Points

3rd Resistance Point 0.7991
2nd Resistance Point 0.7495
1st Resistance Point 0.6901
Last Price 0.6383
1st Support Level 0.5811
2nd Support Level 0.5315
3rd Support Level 0.4721

See More

52-Week High 142.3560
Fibonacci 61.8% 88.2018
Fibonacci 50% 71.4735
Fibonacci 38.2% 54.7452
Last Price 0.6383
52-Week Low 0.5910

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals